CME Group Inc. $CME Shares Purchased by Van Den Berg Management I Inc.

Posted by Geri Gentry on Aug 30th, 2026

Van Den Berg Management I Inc. increased its position in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 19.4% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 22,089 shares of the financial services provider’s stock after buying an additional 3,591 shares during the quarter. Van Den Berg Management I Inc.’s holdings in CME Group were worth $4,878,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in the company. Empowered Funds LLC increased its holdings in shares of CME Group by 11.5% in the 1st quarter. Empowered Funds LLC now owns 10,027 shares of the financial services provider’s stock valued at $2,660,000 after acquiring an additional 1,037 shares during the period. Marshall Wace LLP boosted its stake in CME Group by 103.1% during the 2nd quarter. Marshall Wace LLP now owns 3,692 shares of the financial services provider’s stock worth $1,018,000 after purchasing an additional 121,707 shares during the period. Federated Hermes Inc. boosted its stake in CME Group by 1,325.2% during the 2nd quarter. Federated Hermes Inc. now owns 23,572 shares of the financial services provider’s stock worth $6,497,000 after purchasing an additional 21,918 shares during the period. Nebula Research & Development LLC purchased a new position in CME Group during the 2nd quarter worth $992,000. Finally, The Manufacturers Life Insurance Company increased its stake in CME Group by 2.6% in the second quarter. The Manufacturers Life Insurance Company now owns 287,876 shares of the financial services provider’s stock valued at $79,344,000 after purchasing an additional 7,397 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Price Performance

CME stock opened at $285.80 on Friday. The firm has a 50 day moving average of $253.80 and a 200-day moving average of $279.13. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. The company has a market cap of $102.77 billion, a price-to-earnings ratio of 24.24, a PEG ratio of 3.40 and a beta of 0.23.

CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The business had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same quarter in the prior year, the firm posted $2.96 EPS. The company’s revenue was up .8% compared to the same quarter last year. As a group, equities analysts expect that CME Group Inc. will post 12.27 EPS for the current fiscal year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be issued a $1.30 dividend. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.8%. CME Group’s dividend payout ratio is 44.11%.

Insiders Place Their Bets

In other news, Director William R. Shepard purchased 325 shares of the company’s stock in a transaction dated Thursday, June 25th. The stock was acquired at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the transaction, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. This represents a 0.12% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link. Company insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

CME has been the subject of several recent research reports. Barclays decreased their target price on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research note on Thursday, July 9th. Erste Group Bank cut CME Group from a “buy” rating to a “hold” rating in a research report on Friday, June 5th. Piper Sandler lowered their target price on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research note on Wednesday, July 15th. UBS Group dropped their target price on CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a report on Monday, July 6th. Finally, JPMorgan Chase & Co. upped their price target on CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a research note on Thursday, July 23rd. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, CME Group presently has a consensus rating of “Hold” and a consensus target price of $288.56.

View Our Latest Research Report on CME

CME Group Company Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.